Investing.com - Financial Markets Worldwide
Get 50% Off
🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

UPDATE 1-Fund manager Ackman calls Valeant 'very valuable asset'

Published 2016-03-08, 06:42 p/m
© Reuters. UPDATE 1-Fund manager Ackman calls Valeant 'very valuable asset'
PSON
-
BHC
-
SQ
-

(Adds further comments from Ackman)
By Svea Herbst-Bayliss
NEW YORK, March 8 (Reuters) - Billionaire investor Bill
Ackman on Tuesday called embattled drug company Valeant
Pharmaceuticals VRX.TO a "very valuable asset" but forecast
that if the company's situation does not stabilize soon new
management will be brought in or the company will be sold.
"It will be a messy fourth quarter and a messy first quarter
but after that things should stabilize," Ackman, whose Pershing
Square (NYSE:SQ) Capital Management is Valeant's third largest owner said
at the Harbor Investment Conference.
Valeant's share price has tumbled 68 percent since Ackman
first bought the stock a year ago. Recently the company said it
would have to restate earnings, delayed an earnings call and saw
its chief executive return unexpectedly from a long sick leave.
Ackman said that Valeant has a portfolio of valuable
products and cited its Bausch and Lomb unit as one of the
company's jewels.
While trading in the stock has been volatile recently with
investors worried about what may happen next, Ackman said that
he expects more clarity soon.
Also chief executive Michael Pearson (LON:PSON), who helped build the
company, recently came back from an extended sick leave after
battling pneumonia. Ackman has previously said publicly that he
backed Pearson.
"A lot of the uncertainty will lift in the next weeks," he
said referring to the earnings statement that is expected to be
filed next week.
But Ackman conceded that Valeant is "the most contrarian
stock investment you can own right now,"

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.